Suzetrigine

FDA Drug Profile — JOURNAVX

Suzetrigine is listed in the FDA National Drug Code directory with 11 NDC codes, marketed under brand name including JOURNAVX. Available dosage forms: powder, tablet, film coated.

Drug details

Generic Name
Suzetrigine
Brand Names
JOURNAVX
Application Number
NDA219209
Sponsor
Shanghai SynTheAll Pharmaceutical Co., Ltd.
NDC Codes
11
Dosage Forms
POWDER, TABLET, FILM COATED
Routes
ORAL
Active Ingredients
SUZETRIGINE

Indications and Usage

1 INDICATIONS AND USAGE JOURNAVX is indicated for the treatment of moderate to severe acute pain, including postoperative pain, in adults. JOURNAVX is a sodium channel blocker indicated for the treatment of moderate to severe acute pain, including postoperative pain, in adults. ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.